Fundraising Fox
/Companies
Sign in

Sequel

Manchester, US · 13 known investors

Find your way into Sequel

Sign up to see every warm intro you have to Sequel

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Sequel team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Sequel Med Tech develops wearable insulin delivery devices and precise drug delivery technology for people with diabetes and others, building on the legacy of the insulin pump. The company serves people with type 1 diabetes and healthcare providers, with plans to support drug delivery beyond diabetes.

Digital HealthHardwareHealthtechMedical Devices

Investors · 13

Alumni VenturesreportedManchester · $100K – $10M

How we know: businessinsider.com · Not right? Tell us

Graph VenturesreportedNew York · $50K – $300K

How we know: funding news · femtechinsider.com · Not right? Tell us

Great Oaks Venture CapitalreportedNew York · $50K – $500K

How we know: prweb.com · Not right? Tell us

Growth Warrior CapitalreportedCarson City · $1M – $1.5M

How we know: prweb.com · Not right? Tell us

Javelin Venture PartnersreportedSan Francisco · $500K – $4M

How we know: funding news · businessinsider.com · Not right? Tell us

Long Journey VenturesreportedSan Francisco · $100K – $1M

How we know: funding news · femtechinsider.com · Not right? Tell us

Social LeveragereportedScottsdale · $1M – $2M

How we know: businessinsider.com · Not right? Tell us

Struck CapitalreportedSanta Monica · $500K – $2M

How we know: businessinsider.com · Not right? Tell us

Ulu VenturesreportedPalo Alto · $2M

How we know: funding news · femtechinsider.com · Not right? Tell us

Also in the syndicate · 3

MaC VCPear AcceleratorV1VC

Funding

SEC filings, press & company announcements

$8M disclosed across 1 of 4 rounds · 2021–2022

Source: company announcements and press reports — follow each round's link for the claim.

Related companies · 2

Tandem Diabetes Care, Inc.Tandem Diabetes manufactures infusion sets—tubing systems with subcutaneous delivery sites—designed for use with insulin pumps to manage diabetes. The product line includes several models (AutoSoft XC, AutoSoft 30, VariSoft, TruSteel) with varying insertion angles and tubing lengths.
DiabetesA nonprofit organization that provides educational resources and information about prediabetes, including prevention strategies and lifestyle management for Americans at risk of developing type 2 diabetes.

Companies working in the same space as Sequel.

Frequently asked questions

What does Sequel do?
Sequel Med Tech develops wearable insulin delivery devices and precise drug delivery technology for people with diabetes and others, building on the legacy of the insulin pump. The company serves people with type 1 diabetes and healthcare providers, with plans to support drug delivery beyond diabetes.
Who are Sequel's investors?
Sequel's investors include FemHealth Ventures, Alumni Ventures, Graph Ventures, Great Oaks Venture Capital, Growth Warrior Capital, Javelin Venture Partners, Long Journey Ventures, Social Leverage and 2 more.
How much funding has Sequel raised?
Sequel has disclosed $8M raised across 1 of its 4 known rounds.
Where is Sequel headquartered?
Sequel is headquartered in Manchester, US.